Immune checkpoint inhibition in the era of COVID-19

J. Kurzhals; P. Terheyden; E. A. Langan

doi:10.1111/ced.14370

Immune checkpoint inhibition in the era of COVID-19

J. Kurzhals, P. Terheyden, E. A. Langan^*

^*Corresponding author for this work

Department of Dermatology, Allergology and Venereology

1 Citation (Scopus)

Original language	English
Journal	Clinical and Experimental Dermatology
Volume	46
Issue number	1
Pages (from-to)	176-179
Number of pages	4
ISSN	0307-6938
DOIs	https://doi.org/10.1111/ced.14370
Publication status	Published - 01.2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Coronavirus related work

Research on SARS-CoV-2 / COVID-19

Access to Document

10.1111/ced.14370

Cite this

@article{0d14edfdf17740e5b4588e584743db8a,

title = "Immune checkpoint inhibition in the era of COVID-19",

author = "J. Kurzhals and P. Terheyden and Langan, \{E. A.\}",

year = "2021",

month = jan,

doi = "10.1111/ced.14370",

language = "English",

volume = "46",

pages = "176--179",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Immune checkpoint inhibition in the era of COVID-19

AU - Kurzhals, J.

AU - Terheyden, P.

AU - Langan, E. A.

PY - 2021/1

Y1 - 2021/1

UR - https://www.scopus.com/pages/publications/85090791640

UR - https://www.mendeley.com/catalogue/b60fc72d-7014-34a0-84e2-42968a054253/

U2 - 10.1111/ced.14370

DO - 10.1111/ced.14370

M3 - Letters

C2 - 32640049

AN - SCOPUS:85090791640

SN - 0307-6938

VL - 46

SP - 176

EP - 179

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 1

ER -

Immune checkpoint inhibition in the era of COVID-19

UN SDGs

Research Areas and Centers

Coronavirus related work

Access to Document

Other files and links

Cite this